
Cancer genetics have landed in the age of precision medicine where physicians & patients no longer have to trial & error for treatment options
Innovative Technologies To Detect Cancers Genetic Alteration

At Oncode, we deliver personalized solutions that best suit your needs, because we care
Oncode's reader-friendly, colour-guided comprehensive report is all you need in the design of treatment plans


Cancer genetics have landed in the age of precision medicine where physicians & patients no longer have to trial & error for treatment options
Innovative Technologies To Detect Cancers Genetic Alteration

At Oncode, we deliver personalized solutions that best suit your needs, because we care

Oncode's reader-friendly, colour-guided comprehensive report is all you need in the design of treatment plans

Cancer genetics have landed in the age of precision medicine where physicians & patients no longer have to trial & error for treatment options
Innovative Technologies To Detect Cancers Genetic Alteration
At Oncode, we deliver personalized solutions that best suit your needs, because we care
Oncode's reader-friendly, colour-guided comprehensive report is all you need in the design of treatment plans
Tailor-made solutions best suited for your needs
SOLID TUMOURS
BLOOD CANCERS
Myeloproliferative Neoplasms (MPN)
From single gene PCR assays to panels of Next Generation Sequencing (NGS) assays are available for the detection of mutation(s) & fusion(s) in MPN.
ACUTE MYELOID LEUKEMIA (AML)
From single gene PCR assays to panels of Next Generation Sequencing (NGS) assays are available for the detection of mutation(s) & fusion(s) in AML.
Acute Lymphoblastic Leukemia (ALL)
PCR and Next Generation Sequencing assays for the detection of fusion(s) in ALL.
Non-Hodgkin’s Lymphoma (NHL)
Assays including BRAF and/ or MYD88 PCR panels for the detection of mutation(s) in NHL.
Tailor-made solutions best suited for your needs
SOLID TUMOURS
BLOOD CANCERS
Myeloproliferative Neoplasms (MPN)
From single gene PCR assays to panels of Next Generation Sequencing (NGS) assays are available for the detection of mutation(s) & fusion(s) in MPN.
ACUTE MYELOID LEUKEMIA (AML)
From single gene PCR assays to panels of Next Generation Sequencing (NGS) assays are available for the detection of mutation(s) & fusion(s) in AML.
Acute Lymphoblastic Leukemia (ALL)
PCR and Next Generation Sequencing assays for the detection of fusion(s) in ALL.
Non-Hodgkin’s Lymphoma (NHL)
Assays including BRAF and/ or MYD88 PCR panels for the detection of mutation(s) in NHL.
Tailor-made solutions best suited for your needs
SOLID TUMOURS
BLOOD CANCERS
Myeloproliferative Neoplasms (MPN)
From single gene PCR assays to panels of Next Generation Sequencing (NGS) assays are available for the detection of mutation(s) & fusion(s) in MPN.
ACUTE MYELOID LEUKEMIA (AML)
From single gene PCR assays to panels of Next Generation Sequencing (NGS) assays are available for the detection of mutation(s) & fusion(s) in AML.
Acute Lymphoblastic Leukemia (ALL)
PCR and Next Generation Sequencing assays for the detection of fusion(s) in ALL.
Non-Hodgkin’s Lymphoma (NHL)
Assays including BRAF and/ or MYD88 PCR panels for the detection of mutation(s) in NHL.

Here at Oncode we Offer
World Class Premium Laboratory Services





Here at Oncode we Offer
World Class Premium Laboratory Services



